Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Mar 27;14:7293. doi: 10.1038/s41598-024-57199-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

(A) Percentage of patients with the respective perimetry abnormalities for each group. (MS—optic neuritis, CIS—optic neuritis, suspected optic neuritis). MS, multiple sclerosis; CIS, clinically isolated syndrome; sON, suspected optic neuritis. (B) Proportion of patients with objectifiable findings such as RAPD, abnormalities in MRI of the optic nerve or VEP for the groups MS—optic neuritis and CIS—optic neuritis. By definition, the sON group did not show any objectifiable abnormalities for optic neuritis, as this would at least have meant classification in the CIS group. RAPD, relative afferent pupillary deficit, VEP, visual evoked potential; MRI, magnetic resonance imaging. MS, multiple sclerosis; CIS, clinically isolated syndrome. (C) Percentage of patients with the respective CSF finding for each group. (MS—optic neuritis, CIS—optic neuritis, suspected optic neuritis). CSF, cerebrospinal fluid; OCB, oligoclonal bands; MS, multiple sclerosis; CIS, clinically isolated syndrome; sON, suspected optic neuritis.